These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1990708)

  • 1. Inhibition of skin graft rejection in mice by rapamycin: a novel immunosuppressive macrolide.
    Eng CP; Gullo-Brown J; Chang JY; Sehgal SN
    Transplant Proc; 1991 Feb; 23(1 Pt 1):868-9. PubMed ID: 1990708
    [No Abstract]   [Full Text] [Related]  

  • 2. A study of the contrasting effects of cyclosporine, FK 506, and rapamycin on the suppression of allograft rejection.
    Morris RE; Wu J; Shorthouse R
    Transplant Proc; 1990 Aug; 22(4):1638-41. PubMed ID: 1697111
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative study of toxicity and efficacy of cyclosporine, cyclosporine G (OG37), FK 506, and rapamycin in BALB/c mice with fitted skin grafts.
    Masri MA
    Transplant Proc; 1995 Feb; 27(1):366. PubMed ID: 7533412
    [No Abstract]   [Full Text] [Related]  

  • 4. Synergistic effect of immunosuppressive drug and intrathymic inoculation of donor cells in skin graft survival.
    Dono K; Wood ML; Ozato H; Monaco AP
    Transplant Proc; 1994 Oct; 26(5):3061. PubMed ID: 7940963
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of rapamycin for the suppression of alloimmune reactions in vivo: schedule dependence, tolerance induction, synergy with cyclosporine and FK 506, and effect on host-versus-graft and graft-versus-host reactions.
    Morris RE; Meiser BM; Wu J; Shorthouse R; Wang J
    Transplant Proc; 1991 Feb; 23(1 Pt 1):521-4. PubMed ID: 1703698
    [No Abstract]   [Full Text] [Related]  

  • 6. Extended skin allo- and xenograft survival in mice treated with rapamycin, antilymphocyte serum, and donor-specific bone marrow transfusion.
    Hale DA; Gottschalk R; Fukuzaki T; Wood ML; Maki T; Monaco AP
    Transplant Proc; 1996 Dec; 28(6):3269. PubMed ID: 8962269
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of rapamycin on islet and skin xenograft survival.
    Bobbio SA; Porter JG; Monaco AP
    Transplant Proc; 1993 Aug; 25(4):2745-6. PubMed ID: 8356733
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of rapamycin on induction of unresponsiveness in ALS-treated, marrow-injected mice.
    Bobbio SA; Wood ML; Monaco AP
    Transplant Proc; 1993 Feb; 25(1 Pt 1):717-8. PubMed ID: 8438453
    [No Abstract]   [Full Text] [Related]  

  • 9. Synergistic interactions of cyclosporine, rapamycin, and brequinar on heart allograft survival in mice.
    Stepkowski SM; Tu Y; Chou TC; Kahan BD
    Transplant Proc; 1994 Oct; 26(5):3025-7. PubMed ID: 7940952
    [No Abstract]   [Full Text] [Related]  

  • 10. Prolongation of skin allograft survival in mice treated with CTLA-4 Ig in combination with rapamycin or cyclosporine.
    Hale DA; Gottschalk R; Wood ML; Maki T; Monaco AP
    Transplant Proc; 1996 Dec; 28(6):3270-1. PubMed ID: 8962270
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of single-dose, late treatment with rapamycin on skin allograft survival in ALS- and donor bone marrow cell-treated mice.
    De Fazio SR; Plowey J; Hartner WC; Gozzo JJ
    Transplant Proc; 1994 Dec; 26(6):3102-3. PubMed ID: 7998084
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy and mechanism of action of rapamycin in presensitized recipients of experimental allografts.
    Chen H; Wu J; Xu D; Luo H; Daloze P
    Transplant Proc; 1992 Oct; 24(5):1669-70. PubMed ID: 1412790
    [No Abstract]   [Full Text] [Related]  

  • 13. Brequinar sodium effectively and potently suppresses allograft rejection in a heterotopic mouse heart transplant model.
    Murphy MP; Morris RE
    Transplant Proc; 1993 Jun; 25(3 Suppl 2):75-6. PubMed ID: 7685955
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapamycin abrogates accelerated rejection in sensitized rats by selectively suppressing intragraft cell activation, adhesion/binding properties, and modulating serum alloantibody responses.
    Schmidbauer G; Hancock WW; Wasowska B; Binder J; Padberg W; Kupiec-Weglinski JW
    Transplant Proc; 1995 Feb; 27(1):427-9. PubMed ID: 7879048
    [No Abstract]   [Full Text] [Related]  

  • 15. Donor pretreatment with rapamycin delays rejection following intestinal allotransplantation.
    He G; Zhong R; Zhang Z; Garcia B; Black R; Duff J; Grant D
    Transplant Proc; 1992 Jun; 24(3):1178. PubMed ID: 1604577
    [No Abstract]   [Full Text] [Related]  

  • 16. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin.
    Dono K; Maki T; Wood ML; Monaco AP
    Transplantation; 1995 Dec; 60(11):1268-73. PubMed ID: 8525521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of skin graft survival rates in BALB/c mice treated with either cyclosporine A, cyclosporine G, or 1/1 combination of both.
    Masri MA
    Transplant Proc; 1992 Oct; 24(5):1661-2. PubMed ID: 1412788
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term limb allograft survival using a short course of anti-CD45RB monoclonal antibody, LF 15-0195, and rapamycin in a mouse model.
    Zhong T; Liu Y; Jiang J; Wang H; Temple CL; Sun H; Garcia B; Zhong R; Ross DC
    Transplantation; 2007 Dec; 84(12):1636-43. PubMed ID: 18165776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolongation by rapamycin of heart, kidney, pancreas, and small bowel allograft survival in rats.
    Stepkowski SM; Chen H; Daloze P; Kahan BD
    Transplant Proc; 1991 Feb; 23(1 Pt 1):507-8. PubMed ID: 1990602
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of rapamycin in orthotopic small bowel transplantation in the rat.
    Marquet RL; de Bruin RW; Heineman E; Jeekel J
    Transplant Proc; 1993 Aug; 25(4):2695-6. PubMed ID: 8356718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.